Related Experiment Video

Updated: Dec 15, 2025

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis
11:44

Analysis of Combinatorial miRNA Treatments to Regulate Cell Cycle and Angiogenesis

Published on: March 30, 2019

7.9K

MiR-613 blocked the progression of cervical cancer by targeting LETM1

H Ji1, N-J Hu

  • 1Department of Obstetrics and Gynecology, The First Affiliated Hospital of Jinzhou Medical University, Jinzhou, China. jirujing2010@163.com.

European Review for Medical and Pharmacological Sciences
|July 8, 2020
PubMed
Abstract

Insights

MicroRNA-613 (miR-613) is suppressed in cervical squamous cell cancer (CSCC). Restoring miR-613 inhibits CSCC cell proliferation and invasion by targeting LETM1, suggesting a potential therapeutic target.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biochemistry

Background:

  • Cervical squamous cell cancer (CSCC) is a significant global health concern.
  • The role of microRNAs (miRNAs) in cancer development is increasingly recognized.
  • Understanding specific miRNA functions, like miR-613, is crucial for targeted therapies.

Purpose of the Study:

  • To investigate the role of miR-613 in cervical squamous cell cancer (CSCC) development.
  • To elucidate the molecular mechanism underlying miR-613's function in CSCC.
  • To identify potential therapeutic targets for CSCC based on miR-613.

Main Methods:

  • Quantitative Real Time-Polymerase Chain Reaction (qRT-PCR) to measure miR-613 expression in CSCC tissues and cells.
  • Bioinformatics and Luciferase reporter assays to identify miR-613 targets.
  • In vitro assays (CCK-8, wound healing, transwell) to assess cell proliferation, invasion, and migration.
  • Western blot to analyze protein expression changes.

Main Results:

  • miR-613 expression was significantly downregulated in CSCC tissues and cells compared to normal controls.
  • LETM1 was identified as a direct target of miR-613.
  • miR-613 suppressed the proliferation, invasion, and migration of CSCC cells (SiHa) in vitro.
  • Overexpression of LETM1 reversed the anti-cancer effects of miR-613.

Conclusions:

  • miR-613 plays a tumor-suppressive role in cervical squamous cell cancer (CSCC).
  • The miR-613/LETM1 signaling pathway is implicated in CSCC progression.
  • This pathway represents a potential therapeutic target for CSCC diagnosis and treatment.

More Related Videos

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice07:02

In Vivo Inhibition of MicroRNA to Decrease Tumor Growth in Mice

Published on: August 23, 2019

7.7K
Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics06:00

Through the Looking Glass: Time-lapse Microscopy and Longitudinal Tracking of Single Cells to Study Anti-cancer Therapeutics

Published on: May 14, 2016

11.3K

Related Concept Videos

MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns—non-coding regions of a gene—or intergenic regions—stretches of DNA present between genes. Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After...
23.7K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.5K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
7.5K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.5K